These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2488366)

  • 1. Oral lecithin improves ultrafiltration in patients on peritoneal dialysis.
    Chan H; Abraham G; Oreopoulos DG
    Perit Dial Int; 1989; 9(3):203-5. PubMed ID: 2488366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylcholine administration in continuous ambulatory peritoneal dialysis (CAPD) patients with reduced ultrafiltration.
    De Vecchi A; Castelnovo C; Guerra L; Scalamogna A
    Perit Dial Int; 1989; 9(3):207-10. PubMed ID: 2488367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Krack G; Viglino G; Cavalli PL; Gandolfo C; Magliano G; Cantaluppi A; Peluso F
    Perit Dial Int; 1992; 12(4):359-64. PubMed ID: 1420493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis.
    Chan PC; Tam SC; Robinson JD; Yu L; Ip MS; Chan CY; Cheng IK
    Nephron; 1991; 59(1):100-3. PubMed ID: 1944720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetate dialysate: responsible for decrease in ultrafiltration in continuous ambulatory peritoneal dialysis].
    Faller B; Marichal JF
    Nephrologie; 1984; 5(2):71-6. PubMed ID: 6483075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylcholine and peritoneal dialysis.
    Williams JD; Beavis JM
    Contrib Nephrol; 1990; 85():142-9. PubMed ID: 2078933
    [No Abstract]   [Full Text] [Related]  

  • 7. Three exchanges with a 2.5-liter volume for continuous ambulatory peritoneal dialysis.
    Twardowski Z; Janicka L
    Kidney Int; 1981 Aug; 20(2):281-4. PubMed ID: 7289408
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritoneal dialysis.
    Nolph KD; Twardowski ZJ; Khanna R
    ASAIO Trans; 1986; 32(1):11-6. PubMed ID: 3778693
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients.
    Querques M; Procaccini DA; Pappani A; Strippoli P; Passione A
    ASAIO Trans; 1990; 36(3):M581-3. PubMed ID: 2252756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
    Drachman R; Niaudet P; Gagnadoux MF; Broyer M
    Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of fluid overload in infants by tidal peritoneal dialysis: is there a benefit compared with continuous cycling peritoneal dialysis?
    Fischbach M; Desprez P; Hamel G; Donnars F; Geisert J
    Pediatr Nephrol; 1994 Oct; 8(5):598-600. PubMed ID: 7819011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous ambulatory peritoneal dialysis using self-made, ultrafiltration-sterilized, L-lactate-based dialysis solution.
    Ing TS; Yu AW; Agrawal B; Tiwari PK; McShane AP; Kuna PP; Gandhi VC
    Int J Artif Organs; 1994 Sep; 17(9):488-91. PubMed ID: 7890437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
    Radovanović Lj; Popović J; Radlović O
    Srp Arh Celok Lek; 1988; 116(11-12):967-76. PubMed ID: 3247614
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemofiltration--an improved method of treatment for chronic renal failure.
    Quellhorst E; Scheunemann B; Hildebrand U
    Contrib Nephrol; 1985; 44():194-211. PubMed ID: 3987286
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients.
    Rojas-Campos E; Cortés-Sanabria L; Martínez-Ramírez HR; González L; Martín-del-Campo F; González-Ortiz M; Cueto-Manzano AM
    Perit Dial Int; 2005; 25(6):576-82. PubMed ID: 16411525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic dilemma of ultrafiltration failure in a continuous ambulatory peritoneal dialysis patient.
    Yuvaraj A; Koshy PJ; Rohit A; Nagarajan P; Nair S; Revathi L; Abraham G
    Perit Dial Int; 2015; 35(2):233-4. PubMed ID: 25904776
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal replacement therapy utilizing hemodialysis and peritoneal dialysis.
    Paganini EP; Vidt DG
    Urol Clin North Am; 1983 May; 10(2):347-67. PubMed ID: 6344391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.